COMMUNIQUÉS West-GlobeNewswire

Michael Phelps, World Champion Athlete and Mental Health Advocate, Appointed to Medibio Board of Directors
05/06/2017
SYDNEY, Australia, June 05, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB) (MEB or the Company), an ASX listed medical technology company that has developed an effective objective test to assist in the diagnosis of [...]
Innate Pharma acquiert l'anti-C5aR, un anticorps en Phase clinique, auprès de Novo Nordisk A/S
02/06/2017
INNATE PHARMA RENFORCE SON PORTEFEUILLE D'ANTICORPS PROPRIÉTAIREs AVEC L'ACQUISITION DE L'ANTI-C5 aR, UN ANTICORPS AU STADE CLINIQUE, AUPRÈS DE NOVO NORDISK A/S L'anti-C5aR est un anticorps thérapeutique « first-in- [...]
Souris dans l'espace : des souris de Taconic incluses dans le lancement vers la Station spatiale internationale
02/06/2017
HUDSON, New York, le 2 e juin 2017 (GLOBE NEWSWIRE) - Lorsque l'astronef SpaceX Dragon sera lancé aujourd'hui vers la Station spatiale internationale, il sera rejoint par 40 souris spéciales, élevées spécifiquement pour [...]
Virbac : Déclaration d'actions et de droits de vote au 31 Mai 2017
02/06/2017
DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]
Virbac : Declaration of the number of shares and voting rights as of May 2017, 31.
02/06/2017
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
XBiotech présente des résultats de phase III pour son traitement par anticorps du cancer colorectal lors de la réunion ASCO de 2017
02/06/2017
Les données montrent une moindre progression de la maladie et une survie améliorée pour les patients atteignant le critère d'évaluation principal AUSTIN, Texas, le 1 er juin 2017 (GLOBE NEWSWIRE) - XBiotech Inc. (NASDAQ [...]
Nexstim Plc Agrees on Extension of Tekes R&D Loan Repayments
02/06/2017
Company announcement, Helsinki, 2 June 2017 at 2:30 pm Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]
Crown Bioscience affiche une maîtrise approfondie des modèles PDX et une expertise émergente en immuno-oncologie
02/06/2017
Avancées scientifiques en immuno-oncologie post-AACR SANTA CLARA, Californie, 2017-06-02 (GLOBE NEWSWIRE) - Crown Bioscience , une filiale en propriété exclusive de Crown Bioscience International (TWSE : code boursier [...]
Orion Diagnostica's co-operation negotiations in Oulu completed
02/06/2017
ORION CORPORATION PRESS RELEASE 2 JUNE 2017 at 11.06 a.m. EEST Orion Diagnostica's co-operation negotiations in Oulu completed The co-operation negotiations which were initiated in April in Orion Diagnostica Oy, a [...]
Zealand to present at two international healthcare investor conferences in June 2017
02/06/2017
Press Release - No. 4 / 2017 Zealand to present at two international healthcare investor conferences in June 2017 Copenhagen, June 2, 201 7 - Zealand announces that its President and CEO, Britt Meelby Jensen, and [...]
Tecan appoints Erik Norström Head of Corporate Development
02/06/2017
Männedorf, Switzerland, June 2, 2017 - The Tecan Group (SIX Swiss Exchange: TECN) announced today that Erik Norström has been appointed Head of Corporate Development and a member of the Management Board. He will assume [...]
Novartis presents updated data that reinforce the efficacy and safety of Kisqali® (ribociclib) plus letrozole as a first-line option for HR+/HER2- advanced or metastatic breast cancer
02/06/2017
At a subsequent analysis of the MONALEESA-2 trial, after nearly one year of additional follow-up, Kisqali plus letrozole demonstrated median progression-free survival (PFS) of 25.3 months compared to 16.0 months for [...]
Basilea names new member of its Extended Management Committee
02/06/2017
Basel, Switzerland, June 2, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced that, as of August 1, 2017, Damian Heller will assume the role of General Counsel & Corporate Secretary and join the Extended [...]
Biocartis Group NV: Disclosure of a transparency notification
02/06/2017
PRESS RELEASE: REGULATED INFORMATION 2 June 2017, 07:00 CEST Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Mechelen, Belgium, 2 [...]
Merus fera une présentation à la Jefferies 2017 Global Healthcare Conference
02/06/2017
UTRECHT, Pays-Bas, le 1 er juin 2017 - Merus N.V. (Nasdaq : MRUS), une entreprise d'immuno-oncologie de stade clinique qui développe des traitements innovants à base d'anticorps bispécifiques, a annoncé aujourd'hui que [...]
Mice in Space: Taconic Mice Included on Launch to International Space Station
01/06/2017
HUDSON, N.Y., June 01, 2017 (GLOBE NEWSWIRE) -- When the SpaceX Dragon spacecraft launches today bound for the International Space Station, they will be joined by 40 special mice, bred specifically for this mission by [...]
NICOX : Nombre de droits de vote au 31 mai 2017
01/06/2017
Nicox SA Société anonyme au capital de 25 070 977 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1 juin 2017, PUBLICATION MENSUELLE DU NOMBRE D'ACTIONS [...]
NICOX : Number of voting rights as of May 31, 2017
01/06/2017
Nicox SA Société anonyme with a registered capital of € 25,070,977 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On June 1, 2017, MONTHLY PUBLICATION OF THE [...]
Bavarian Nordic to Present at Jefferies 2017 Healthcare Conference in New York
01/06/2017
COPENHAGEN, Denmark - June 1, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Paul Chaplin, President & Chief Executive Officer will provide a corporate presentation at the Jefferies 2017 [...]

Pages